Tig Advisors, LLC Moon Lake Immunotherapeutics Call Options Transaction History

Tig Advisors, LLC

  • $1.38 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.43 - $48.6 $142,191 - $179,820
3,700 Added 72.55%
8,800 $386,000
Q1 2024

May 15, 2024
SELL
$43.78 - $63.86 $4.41 Million - $6.44 Million
-100,800 Reduced 95.18%
5,100 $256,000
Q4 2023

Feb 14, 2024
BUY
$36.35 - $63.02 $3.85 Million - $6.67 Million
105,900 New
105,900 $6.4 Million

Others Institutions Holding MLTX

# of Institutions
127
Shares Held
58M
Call Options Held
103K
Put Options Held
79.7K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.82B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Tig Advisors, LLC Portfolio

Follow Tig Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tig Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email